Pub. Date : 2007 May
PMID : 17441804
6 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Triple therapy of initial high-dose interferon with ribavirin and amantadine for patients with chronic hepatitis C. AIMS: We previously reported the potential effect of combination therapy of an initial high-dose interferon (IFN) and amantadine on the eradication of HCV-RNA in patients with chronic hepatitis C. The additive effects of amantadine on interferon and ribavirin combination therapy remain controversial. | Amantadine | interferon alpha 1 | Homo sapiens |
| 2 | Triple therapy of initial high-dose interferon with ribavirin and amantadine for patients with chronic hepatitis C. AIMS: We previously reported the potential effect of combination therapy of an initial high-dose interferon (IFN) and amantadine on the eradication of HCV-RNA in patients with chronic hepatitis C. The additive effects of amantadine on interferon and ribavirin combination therapy remain controversial. | Amantadine | interferon alpha 1 | Homo sapiens |
| 3 | Triple therapy of initial high-dose interferon with ribavirin and amantadine for patients with chronic hepatitis C. AIMS: We previously reported the potential effect of combination therapy of an initial high-dose interferon (IFN) and amantadine on the eradication of HCV-RNA in patients with chronic hepatitis C. The additive effects of amantadine on interferon and ribavirin combination therapy remain controversial. | Amantadine | interferon alpha 1 | Homo sapiens |
| 4 | Triple therapy of initial high-dose interferon with ribavirin and amantadine for patients with chronic hepatitis C. AIMS: We previously reported the potential effect of combination therapy of an initial high-dose interferon (IFN) and amantadine on the eradication of HCV-RNA in patients with chronic hepatitis C. The additive effects of amantadine on interferon and ribavirin combination therapy remain controversial. | Amantadine | interferon alpha 1 | Homo sapiens |
| 5 | CONCLUSION: Triple therapy with an initial high dose of IFN with ribavirin and amantadine may be effective, especially for chronic hepatitis C IFN-retreatment patients with a high viral load of genotype 1b. | Amantadine | interferon alpha 1 | Homo sapiens |
| 6 | CONCLUSION: Triple therapy with an initial high dose of IFN with ribavirin and amantadine may be effective, especially for chronic hepatitis C IFN-retreatment patients with a high viral load of genotype 1b. | Amantadine | interferon alpha 1 | Homo sapiens |